Two Sigma Investments, LP Adverum Biotechnologies, Inc. Transaction History

Two Sigma Investments, LP

$42.3 Billion
Q3 2024

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$0.75 - $1.26 $53,729 - $90,265	-71,639 Reduced 13.83%	446,396 $334,000
Q3 2023 Nov 14, 2023	BUY	$1.5 - $2.33 $49,042 - $76,179	32,695 Added 6.74%	518,035 $777,000
Q2 2023 Aug 14, 2023	SELL	$0.68 - $1.59 $92,331 - $215,893	-135,782 Reduced 21.86%	485,340 $771,000
Q1 2023 May 15, 2023	SELL	$0.62 - $0.85 $53,645 - $73,546	-86,525 Reduced 12.23%	621,122 $447,000
Q4 2022 Feb 14, 2023	SELL	$0.54 - $10.3 $183,824 - $3.51 Million	-340,416 Reduced 32.48%	707,647 $410,000
Q3 2022 Nov 14, 2022	SELL	$0.96 - $9.68 $111,839 - $1.13 Million	-116,499 Reduced 10.0%	1,048,063 $996,000
Q2 2022 Aug 15, 2022	SELL	$0.81 - $1.34 $327,268 - $541,406	-404,035 Reduced 25.76%	1,164,562 $1.4 Million
Q1 2022 May 16, 2022	SELL	$1.23 - $1.95 $243,146 - $385,476	-197,680 Reduced 11.19%	1,568,597 $2.06 Million
Q4 2021 Feb 14, 2022	SELL	$1.74 - $2.4 $181,690 - $250,608	-104,420 Reduced 5.58%	1,766,277 $3.11 Million
Q3 2021 Nov 15, 2021	BUY	$2.08 - $3.6 $727,923 - $1.26 Million	349,963 Added 23.01%	1,870,697 $4.06 Million
Q2 2021 Aug 16, 2021	BUY	$3.36 - $10.56 $2.82 Million - $8.86 Million	838,800 Added 123.0%	1,520,734 $5.32 Million
Q1 2021 May 17, 2021	BUY	$9.26 - $14.36 $39,855 - $61,805	4,304 Added 0.64%	681,934 $6.72 Million
Q4 2020 Feb 16, 2021	SELL	$9.84 - $14.26 $3.79 Million - $5.49 Million	-385,161 Reduced 36.24%	677,630 $7.35 Million
Q3 2020 Nov 16, 2020	BUY	$10.3 - $21.64 $10.8 Million - $22.7 Million	1,047,542 Added 6869.58%	1,062,791 $10.9 Million
Q2 2020 Aug 14, 2020	BUY	$8.53 - $25.64 $130,073 - $390,984	15,249 New	15,249 $318,000
Q4 2019 Feb 14, 2020	SELL	$5.12 - $12.22 $581,800 - $1.39 Million	-113,633 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$5.24 - $15.89 $595,436 - $1.81 Million	113,633 New	113,633 $619,000
Q2 2019 Aug 14, 2019	SELL	$5.1 - $11.89 $381,112 - $888,515	-74,728 Closed	0 $0
Q1 2019 May 15, 2019	SELL	$3.03 - $6.02 $600,124 - $1.19 Million	-198,061 Reduced 72.61%	74,728 $392,000
Q4 2018 Feb 14, 2019	BUY	$2.87 - $5.92 $250,909 - $517,556	87,425 Added 47.16%	272,789 $859,000
Q3 2018 Nov 14, 2018	BUY	$4.5 - $7.6 $834,138 - $1.41 Million	185,364 New	185,364 $1.12 Million
Q2 2018 Aug 14, 2018	SELL	$5.3 - $6.9 $91,281 - $118,838	-17,223 Closed	0 $0
Q1 2018 May 15, 2018	SELL	$3.65 - $7.95 $1.17 Million - $2.55 Million	-320,733 Reduced 94.9%	17,223 $100,000
Q4 2017 Feb 14, 2018	BUY	$2.85 - $3.95 $749,390 - $1.04 Million	262,944 Added 350.54%	337,956 $1.18 Million
Q3 2017 Nov 14, 2017	BUY	$2.45 - $3.65 $183,779 - $273,793	75,012	75,012 $274,000

Others Institutions Holding ADVM

# of Institutions

Shares Held

524K

Call Options Held

Put Options Held

Versant Venture Management, LLC San Francisco, CA

507K
Shares

$2.4 Million
9.32% of portfolio
Pinz Capital Management, LP New York, NY

15.7K
Shares

$74,418
0.03% of portfolio
American Portfolios Advisors Holbrook, NY

1.15K
Shares

$5,451
0.0% of portfolio

View Full List

About Adverum Biotechnologies, Inc.

Ticker ADVM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 99,333,600
Market Cap $471M
Description
Adverum Biotechnologies, Inc., a clinical-stage gene therapy company, develops gene therapy product candidates to treat ocular and rare diseases. Its lead product candidate is ADVM-022, a single intravitreal injection gene therapy candidate used for the treatment of patients with chronic retinal, including wet age-related macular degeneration an...

More about ADVM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Investments, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Investments, LP with notifications on news.

Account